Linde PLC
LINNasdaqIndustrial Inorganic ChemicalsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 16/3037% above fair value
$519.72+5.48 (+1.07%)
Close on Nov 2, 2026Market cap $239.58BP/E 34.5Yield 1.15%
Linde Quarterly Reported NOPAT by Quarter
Quarterly Reported NOPAT ($M)
Linde Quarterly Reported NOPAT: $1,793M in Q3 2026, down 11.3% from a year earlier.
Latest, Q3 2026
1,793
Period ended Sep 30, 2026
Change on a year earlier
-11.3%
2,021 in Q3 2025
History
23 quarters
Since Q1 2021
Sources
5
Documents cited below
Where the Q3 2026 figure comes from
“Reported NOPAT $ 1,793 $ 2,018 $ 1,947 $ 1,621 $ 2,021 $ 1,857 $ 1,753”
Source: Linde IR FY2026Q3 Earnings Release & Financial Tables ↗
Reported in Linde IR Financial Tables (Page 14).
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Linde Quarterly Reported NOPAT ($M), quarterly Q1 2021–Q3 2026 [Data set]. Compiled from Linde SEC filings and investor materials. https://stockdatahq.com/stocks/lin/kpis/nopat-rep-q
See every metric in the Linde KPI table. Data updated Oct 31, 2026.